CURE — DIREXION SHS ETF TR

Ownership history in WOLVERINE TRADING, LLC  ·  35 quarters on record

This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in DIREXION SHS ETF TR (CURE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 3,600 -900 -20.0% 0.00% $279K $78.31
2025 Q1 REDUCED 4,500 -200 -4.3% 0.00% $465K $105.49
2023 Q4 ADDED 4,700 +2,100 +80.8% 0.00% $478K $99.46
2023 Q3 REDUCED 2,600 -500 -16.1% 0.00% $230K $86.02
31 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CURE price (monthly, adj. close)

Other funds also holding CURE

As of 2025 Q4 — sorted by position size

Bullseye Investment Management, LLC 3Y 1.06% GTS SECURITIES LLC 0.09% Frazier Financial Advisors, LLC 0.07% Virtu Financial LLC 3Y 7Y 0.06% Traynor Capital Management, Inc. 3Y 7Y 0.03% Onyx Bridge Wealth Group LLC 3Y 0.03% Tower Research Capital LLC (TRC) 3Y 7Y 0.02% Pinnacle Wealth Planning Services, Inc. 3Y 7Y 0.01% Summit Financial, LLC 3Y 7Y 0.0% SUSQUEHANNA INTERNATIONAL GROUP, LLP 3Y 7Y 0.0%
← Back to WOLVERINE TRADING, LLC Holdings